Kaempferol impedes IL-32-induced monocyte-macrophage differentiation

Chemico-Biological Interactions

Volumn 274, Issue , 2017, Pages 107-115

  Nam, Sun Young ^a   Jeong, Hyun Ja ^b   Kim, Hyung Min ^a  

^a Kyung Hee University   (South Korea)

^b Hoseo University   (South Korea)

Author keywords

IL 32; Kaempferol; Macrophage differentiation; Thymic stromal lymphopoietin

Indexed keywords

CASPASE 11; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 32; INTERLEUKIN 8; KAEMPFEROL; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; CYTOKINE; IL32 PROTEIN, HUMAN; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN DERIVATIVE; KAEMPFEROL DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CASPASE ASSAY; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MONOCYTE; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL LINE; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM;

ANTI-INFLAMMATORY AGENTS; CASPASE 1; CELL DIFFERENTIATION; CELL LINE; CYTOKINES; HUMANS; INTERLEUKIN-8; INTERLEUKINS; KAEMPFEROLS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICROSCOPY, CONFOCAL; MONOCYTES; NF-KAPPA B; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85024107841     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2017.07.010     Document Type: Article

References (42)

1. Balkwill, F., Mantovani, A., Inflammation and cancer: back to Virchow?. Lancet 357 (2001), 539–545.
2. Shacter, E., Weitzman, S.A., Chronic inflammation and cancer. Oncol. Willist. Park) 16 (2002), 217–226.
3. Mygind, N., Dahl, R., Pedersen, S., Thestrup-Pedersen, K., Essential Allergy. second ed., 1996, Oxford, London.
4. Egawa, M., Mukai, K., Yoshikawa, S., Iki, M., Mukaida, N., Kawano, Y., Minegishi, Y., Karasuyama, H., Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity 38 (2013), 570–580.
5. Nam, S.Y., Oh, H.A., Choi, Y., Park, K.Y., Kim, H.M., Jeong, H.J., Inhibition of IL-32 signaling by bamboo salt decreases pro-inflammatory responses in cellular models of allergic rhinitis. J. Med. Food 17 (2014), 939–948.
6. Shi, C., Pamer, E.G., Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11 (2011), 762–774.
7. Heo, S.J., Yoon, W.J., Kim, K.N., Ahn, G.N., Kang, S.M., Kang, D.H., Affan, A., Oh, C., Jung, W.K., Jeon, Y.J., Evaluation of anti-inflammatory effect of fucoxanthin isolated from brown algae in lipopolysaccharide-stimulated RAW 264.7 macrophages. Food Chem. Toxicol. 48 (2010), 2045–2051.
8. Asquith, D.L., McInnes, I.B., Emerging cytokine targets in rheumatoid arthritis. Curr. Opin. Rheumatol. 19 (2007), 246–251.
9. Brennan, F., Beech, J., Update on cytokines in rheumatoid arthritis. Curr. Opin. Rheumatol. 19 (2007), 296–301.
10. Calabrese, F., Baraldo, S., Bazzan, E., Lunardi, F., Rea, F., Maestrelli, P., Turato, G., Lokar-Oliani, K., Papi, A., Zuin, R., et al. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 178 (2008), 894–901.
11. Seo, E.H., Kang, J., Kim, K.H., Cho, M.C., Lee, S., Kim, H.J., Kim, J.H., Kim, E.J., Park, D.K., Kim, S.H., et al. Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. J. Microbiol. Biotechnol. 18 (2008), 1606–1612.
12. Montoya, D., Inkeles, M.S., Liu, P.T., Realegeno, S., Teles, R.M., Vaidya, P., Munoz, M.A., Schenk, M., Swindell, W.R., Chun, R., et al. IL-32 is a molecular marker of a host defense network in human tuberculosis. Sci. Transl. Med., 6, 2014 250ra114.
13. Rong, Y., Xiang, X.D., Li, Y.M., Peng, Z.Y., Li, J.X., IL-32 was involved in cigarette smoke-induced pulmonary inflammation in COPD. Clin. Respir. J. 9 (2015), 430–435.
14. Dinarello, C.A., Kim, S.H., IL-32, a novel cytokine with a possible role in disease. Ann. Rheum. Dis., 65, 2006 iii61–64.
15. Meyer, N., Zimmermann, M., Bürgler, S., Bassin, C., Woehrl, S., Moritz, K., Rhyner, C., Indermitte, P., Schmid-Grendelmeier, P., Akdis, M., et al. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J. Allergy Clin. Immunol., 125, 2010, e10.
16. Netea, M.G., Azam, T., Ferwerda, G., Girardin, S.E., Walsh, M., Park, J.S., Abraham, E., Kim, J.M., Yoon, D.Y., Dinarello, C.A., et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 16309–16314.
17. Rajendran, P., Rengarajan, T., Nandakumar, N., Palaniswami, R., Nishigaki, Y., Nishigaki, I., Kaempferol, a potential cytostatic and cure for inflammatory disorders. Eur. J. Med. Chem. 86 (2014), 103–112.
18. Hua, L., Peng, Z., Chia, L.S., Goh, N.K., Tan, S.N., Separation of kaempferols in Impatiens balsamina flowers by capillary electrophoresis with electrochemical detection. J. Chromatogr. A 909 (2001), 297–303.
19. Oh, H.A., Han, N.R., Kim, M.J., Kim, H.M., Jeong, H.J., Evaluation of the effect of kaempferol in a murine allergic rhinitis model. Eur. J. Pharmacol. 718 (2013), 48–56.
20. Jeong, H.J., Nam, S.Y., Oh, H.A., Han, N.R., Kim, Y.S., Moon, P.D., Shin, S.Y., Kim, M.H., Kim, H.M., Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro. Arthritis Res. Ther., 14, 2012 R259.
21. Serbina, N.V., Jia, T., Hohl, T.M., Pamer, E.G., Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26 (2008), 421–452.
22. Auffray, C., Sieweke, M.H., Geissmann, F., Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27 (2009), 669–692.
23. Rankin, J.A., The contribution of alveolar macrophages to hyper-reactive airway disease. J. Allergy Clin. Immunol. 83 (1989), 722–729.
24. Williams, J., Johnson, S., Mascali, J.J., Smith, H., Rosenwasser, L.J., Borish, L., Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. J. Immunol. 149 (1992), 2823–2829.
25. Borish, L., Mascali, J.J., Rosenwasser, L.J., IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes. J. Immunol. 146 (1991), 63–67.
26. Gosset, P. A., Tsicopoulos, B., Wallaert, M., Joseph, A., Capron, Tonnel, A.B., Tumor necrosis factor alpha and interleukin 6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. Am. Rev. Respir. Dis. 146 (1992), 768–774.
27. Demoly, P., Vachier, I., Pene, J., Michel, F.B., Godard, P., Damon, M., IgE produces monocyte superoxide anion release: correlation with CD23 expression, Comparison of patients with asthma, patients with rhinitis and normal subjects. J. Allergy Clin. Immunol. 93 (1991), 108–116.
28. Profita, M., Vignola, A.M., Mirabella, A., Siena, L., Sala, A., Gjomarkaj, M., Bousquet, J., Bonsignore, G., IL-4 and IgE- anti-IgE modulation of 15(S)-hydroxyeicosatetraenoic acid release by mononuclear phagocytes. J. Allergy Clin. Immunol. 103 (1999), 159–164.
29. Gosset, P., Tillie-Leblond, I., Oudin, S., Parmentier, O., Wallaert, B., Joseph, M., Tonnel, A.B., Production of chemokines and pro-inflammatory and anti-inflammatory cytokines by human alveolar macrophages activated by IgE receptors. J. Allergy Clin. Immunol. 103 (1999), 289–297.
30. Netea, M.G., Lewis, E.C., Azam, T., Joosten, L.A., Jaekal, J., Bae, S.Y., Dinarello, C.A., Kim, S.H., Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 3515–3520.
31. Nam, S.Y., Kim, H.M., Jeong, H.J., Attenuation of IL-32-induced caspase-1 and nuclear factor-kB activations by acteoside. Int. Immunopharmacol. 29 (2015), 574–582.
32. + B cells in vitro and signals via a novel mechanism. J. Immunol. 162 (1999), 677–683.
33. Sebastian, K., Borowski, A., Kuepper, M., Friedrich, K., Signal transduction around thymic stromal lymphopoietin (TSLP) in atopic asthma. Cell Commun. Signal, 6, 2008, 5.
34. Ziegler, S.F., The role of thymic stromal lymphopoietin (TSLP) in allergic disorders. Curr. Opin. Immunol. 22 (2010), 795–799.
35. Mou, Z., Xia, J., Tan, Y., Wang, X., Zhang, Y., Zhou, B., Li, H., Han, D., Overexpression of thymic stromal lymphopoietin in allergic rhinitis. Acta. Otolaryngol. 129 (2009), 297–301.
36. Cagnard, N., Letourneur, F., Essabbani, A., Devauchelle, V., Mistou, S., Rapinat, A., Decraene, C., Fournier, C., Chiocchia, G., Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur. Cytokine Netw. 16 (2005), 289–292.
37. Kim, S.H., Han, S.Y., Azam, T., Yoon, D.Y., Dinarello, C.A., Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22 (2005), 131–142.
38. Jeong, H.J., Shin, S.Y., Oh, H.A., Kim, M.H., Cho, J.S., Kim, H.M., IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis. J. Pathol. 224 (2011), 553–563.
39. Oh, H.A., Ryu, J.G., Kim, W.S., Kim, H.M., Jeong, H.J., Therapeutic effects of traditional Korean medicine, Jeechool-Whan in allergic rhinitis model. TANG, 2, 2012, e9.
40. Devi, K.P., Malar, D.S., Nabavi, S.F., Sureda, A., Xiao, J., Nabavi, S.M., Daglia, M., Kaempferol and inflammation: from chemistry to medicine. Pharmacol. Res. 99 (2015), 1–10.
41. Sargeant, H.R., Miller, H.M., Shaw, M.A., Inflammatory response of porcine epithelial IPEC J2 cells to enterotoxigenic E. coli infection is modulated by zinc supplementation. Mol. Immunol. 48 (2011), 2113–2121.
42. Kim, T.W., Joh, E.H., Kim, B., Kim, D.H., Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages. Int. Immunopharmacol. 12 (2012), 110–116.